HDAC2 and chronic obstructive pulmonary disease: In patients with COPD, smoking asthmatics and severe asthma there is a reduction in HDAC2 activity and expression, which prevents corticosteroids switching off activated inflammatory genes (Figure 5)[20,21,22].